Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells

BACKGROUND: Glucocorticoids are frequently used as a primary chemotherapeutic agent in many types of human lymphoid malignancies because they induce apoptosis through activation of the glucocorticoid receptor, with subsequent alteration of a complex network of cellular mechanisms. Despite clinical u...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Aaron L, Garza, Anna S, Johnson, Betty H, Thompson, E Brad
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852544/
https://www.ncbi.nlm.nih.gov/pubmed/17391526
http://dx.doi.org/10.1186/1475-2867-7-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852544/
https://www.ncbi.nlm.nih.gov/pubmed/17391526
http://dx.doi.org/10.1186/1475-2867-7-3

Ejemplares similares